New Jersey Senate Bill S1695

New Jersey 2026-2027 Regular Session

• Introduced: 1/13/26
• Refer: 1/13/26

Caption

Permits corrections officers, firefighters, and police officers to administer epinephrine auto-injector device.

Impact

The introduction of S1695 is significant for state law as it will broaden the scope of responsibilities for first responders. By allowing corrections officers, firefighters, and police officers to administer epinephrine, the bill potentially enhances public health responses and prepares these professionals for quick intervention in critical situations. The measure reflects an active approach to public safety by empowering emergency personnel with the tools necessary to save lives, particularly in environments where immediate medical help might not be available.

Summary

Senate Bill 1695, proposed in the New Jersey Legislature, aims to empower certain public safety personnel, specifically corrections officers, firefighters, and police officers, to administer epinephrine auto-injector devices in emergencies. The bill clarifies existing regulations surrounding who is licensed to handle these devices, stipulating that individuals who complete an approved educational program will receive certification to administer, maintain, and dispose of epinephrine auto-injector devices. This amendment is designed to ensure that trained professionals can effectively respond to life-threatening allergic reactions, such as anaphylaxis, improving emergency response capabilities in various public settings.

Conclusion

Overall, Senate Bill 1695 represents a proactive step towards enhancing emergency medical response capabilities among law enforcement and public safety officials. By clarifying and expanding the responsibilities of these personnel, New Jersey aims to ensure timely and effective treatment for individuals experiencing severe allergic reactions, thereby potentially saving lives in critical situations.

Contention

While the bill is aimed at improving emergency medical responses, there may be points of contention surrounding the implementation of training programs and the responsibility associated with administering medical interventions. There could be concerns from public safety organizations regarding the adequacy of training for such procedures and the liabilities that may arise from administering medications outside of traditional healthcare settings. Additionally, discussions may arise regarding the preparedness of the training programs and whether they adequately equip personnel to handle potentially severe allergic reactions.